Sleeping Bruxism Treatment Market In-Depth Analysis With Current Trends And Future Estimations up to 2023

The MarketWatch News Department was not involved in the creation of this content.

Jan 02, 2021 (Heraldkeepers) — Global Sleeping Bruxism Treatment Market is expected to register 6.7% CAGR and is projected to reach USD 638.2 million by 2023. Sleeping bruxism (SB), also called nocturnal tooth grinding, is a medical condition characterized by clenching or grinding of teeth during sleep. This is the sleep-associated movement disorder characterized by involuntary, unconscious movement during sleep. The use of psychoactive substances such as tobacco, alcohol, antidepressants, cigarette smoking, or caffeine increases sleep disorders and causes daytime sleepiness. Sleep bruxism is highly prevalent in people who consume psychoactive substances.

Browse Sample of the Report @

According to the Medical Expenditure Panel Survey (MEPS) 2013, one in six Americans consume antidepressants or a sedative. The United Nations reported in 2007 that approximately 1 billion people worldwide suffer from neurological disorders such as Alzheimer, Parkinson disease, strokes, multiple sclerosis, epilepsy, and others.

Factors representing the market growth are worldwide increasing the prevalence of sleep bruxism, growing child population, rising prevalence of obstructive sleep apnea, and changing lifestyle across the world. An article published in the Springer Nature journal stated that the prevalence of sleep bruxism is generally considered to be around 8 to 13% of the general population across the globe. On the contrary, the limited availability of treatment options and the high cost of custom-fit night guards are the factors anticipated to restrain the market growth during the forecast period.

Market Dynamics

The globally rising prevalence of obstructive sleep apnea (OSA) or obstructive sleep apnea-hypopnea is likely to propel the demand for sleeping bruxism diagnosis and treatment drugs. According to an article published in Lancet Respiratory Medicine (LRM), currently, the global prevalence of obstructive sleep apnea is estimated to be around 1 billion individuals. Another 425 million adults are expected to have moderate to severe obstructive sleep apnea across the world.


Global sleeping bruxism treatment market has been segmented into type, diagnosis, treatment type, cause, patient type, and end-user.

Based on type, the global market has been divided into primary bruxism and secondary bruxism. Secondary bruxism occurs in the presence of few neurological disorders, medical or psychiatric conditions, or due to the side effects of drugs.

Based on diagnosis, the global market has been segmented into clinical examination, X-rays, electromyographic methods, and polysomnography.

By treatment type, the global market has been bifurcated into dental approaches and medication. The dental approaches segment is further classified into mouth guard and NTI-TSS device. The medication segment has been further categorized into muscle relaxants, Botox injections, and anti-anxiety drugs.

Based on cause, the global market has been segmented into obstructive sleep apnea, gastroesophageal reflux disease (GERD), malocclusion, and sleep paralysis.

By patient type, the global market has been divided into pediatric and adult. The adult segment has been further categorized into male and female.

Based on end-user, the global market has been divided into hospitals and dental clinics.

Regional Analysis

Based on region, the global sleeping bruxism treatment market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Rising prevalence of stress and anxiety, chronic sleep disorders and intermittent sleep problems, changing lifestyle, and the presence of prominent market players in the US and Canada are expected to support the dominance of the Americas during 2018 to 2023. For instance, according to the National Sleep Foundation, presently, 50 to 70 million Americans are affected by chronic sleep disorders and intermittent sleep problems, which significantly diminish health, attentiveness, and safety.

Europe follows the Americas in terms of revenue and is expected to register the fastest market growth over the forecast period. According to the European Orthodontic Society in 2018, sleeping bruxism affected 14% to 20% of children, 8% to 12% of teenagers, and 3% of the old population.

Asia-Pacific would register considerable market growth during the forecast period attributed to the rapid adoption of advanced healthcare technology, fast economic growth, large population size, and rising healthcare investments. As per the data presented by United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the percentage of the population aged 0 to14 was 23.5% in 2018, which is projected to decrease to 17.7% by 2050.

The Middle East & Africa is expected to represent least market growth owing to the less exposure to the healthcare services, lack of awareness about sleeping bruxism, ignorance of dental diseases, and lack of government rules and regulations.

Key Players

The prominent players in the global sleeping bruxism treatment market are Ivoclar Vivadent AG, Ipsen Biopharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Akervall Technologies Inc., PLANMECA OY, Randmark Dental Products, LLC, S4S Dental Laboratory, Patterson Dental Supply, Inc., Henry Schein, Inc., and Pfizer Inc.

These companies have adopted several organic and inorganic growth strategies to gain robust competitive advantages, such as mergers & acquisitions, new product launches, partnerships and collaborations, and joint ventures.

Key Updates

  • In January 2019, Akervall Technologies Inc. launched a smart mouthguard, SISU mouthguards in the US. With this launch, the company extended its product portfolio
  • In April 2018, Royal DSM, a Dutch multinational science-based company dealing in health, nutrition, and materials, partnered with 3Dmouthguard, a Netherlands-based company that digitalizes the complete process of custom made mouthguards, to develop custom-made and instantly printed 3D mouthguards to protect teeth and mouth injuries. This partnership strengthened the company’s position in the competitive market.

Browse More Details of the Report @


Is there a problem with this press release? Contact the source provider Comtex at You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.